FDA NDC Directory · JSON-LD · Markdown

TRANEXAMIC ACID IN SODIUM CHLORIDE

NDC 51754-0108 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametranexamic acid
Labeler / ManufacturerExela Pharma Sciences, LLC
Marketing categoryNew Drug Application (innovator) · App NDA212020
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsTRANEXAMIC ACID (10 mg/mL)
Marketing started20190601
Package count2

External sources

Source: openFDA. Public-domain (CC0).